About: Brent Saunders

An Entity of Type: animal, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Brent Saunders (1969 or 1970) is an American biopharma executive and entrepreneur. He is known for his merger and acquisition activity, having helped oversee the merger between pharmaceutical companies Merck and Schering-Plough, the acquisition of Bausch + Lomb by Valeant Pharmaceuticals, and the $63 billion acquisition of Allergan by Abbvie. He is the founder of special purpose acquisition company (SPAC) Vesper Healthcare Acquisition. Saunders is also executive chairman of medical aesthetics companies The Beauty Health Company and Hugel America.

Property	Value
dbo:abstract	Brent Saunders (1969 or 1970) is an American biopharma executive and entrepreneur. He is known for his merger and acquisition activity, having helped oversee the merger between pharmaceutical companies Merck and Schering-Plough, the acquisition of Bausch + Lomb by Valeant Pharmaceuticals, and the $63 billion acquisition of Allergan by Abbvie. He is the founder of special purpose acquisition company (SPAC) Vesper Healthcare Acquisition. Saunders is also executive chairman of medical aesthetics companies The Beauty Health Company and Hugel America. (en)
dbo:almaMater	dbr:University_of_Pittsburgh dbr:MBA dbr:Temple_University dbr:Juris_Doctor
dbo:birthDate	1970-02-06 (xsd:date)
dbo:birthYear	1970-01-01 (xsd:gYear)
dbo:occupation	dbr:Brent_Saunders__PersonFunction__1
dbo:wikiPageID	71282190 (xsd:integer)
dbo:wikiPageLength	9934 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID	1124217397 (xsd:integer)
dbo:wikiPageWikiLink	dbr:PricewaterhouseCoopers dbr:Schering-Plough dbr:Bausch_+_Lomb dbr:Bausch_Health dbr:University_of_Pittsburgh dbc:1970_births dbc:Living_people dbr:Appaloosa_Management dbr:MBA dbc:American_chief_executives dbr:Allergan dbr:Forest_Laboratories dbr:Parkland_High_School_(Pennsylvania) dbr:Temple_University dbr:Jefferson_Health dbr:Juris_Doctor dbr:South_Whitehall_Township,_Lehigh_County,_Pennsylvania dbr:Merck_Group dbr:Valeant_Pharmaceuticals dbr:Abbvie dbr:Special_purpose_acquisition_company
dbp:almaMater	dbr:MBA dbr:Temple_University Bachelor's, University of Pittsburgh (en) JD, Temple University (en)
dbp:birthDate	0001-02-06 (xsd:gMonthDay)
dbp:imageSize	200 (xsd:integer)
dbp:knownFor	Biopharma executive, entrepreneur (en)
dbp:name	Brent Saunders (en)
dbp:occupation	Chairman of Hugel America (en) Chairman of The Beauty Health Company (en) Founder of Vesper Healthcare Acquisition (en)
dbp:wikiPageUsesTemplate	dbt:Birth_based_on_age_as_of_date dbt:Cn dbt:Infobox_person dbt:Reflist dbt:Short_description
dcterms:subject	dbc:1970_births dbc:Living_people dbc:American_chief_executives
rdf:type	owl:Thing foaf:Person dbo:Person dul:NaturalPerson wikidata:Q19088 wikidata:Q215627 wikidata:Q5 wikidata:Q729 dbo:Animal dbo:Eukaryote dbo:Species schema:Person
rdfs:comment	Brent Saunders (1969 or 1970) is an American biopharma executive and entrepreneur. He is known for his merger and acquisition activity, having helped oversee the merger between pharmaceutical companies Merck and Schering-Plough, the acquisition of Bausch + Lomb by Valeant Pharmaceuticals, and the $63 billion acquisition of Allergan by Abbvie. He is the founder of special purpose acquisition company (SPAC) Vesper Healthcare Acquisition. Saunders is also executive chairman of medical aesthetics companies The Beauty Health Company and Hugel America. (en)
rdfs:label	Brent Saunders (en)
owl:sameAs	wikidata:Brent Saunders https://global.dbpedia.org/id/Geh11
prov:wasDerivedFrom	wikipedia-en:Brent_Saunders?oldid=1124217397&ns=0
foaf:isPrimaryTopicOf	wikipedia-en:Brent_Saunders
foaf:name	Brent Saunders (en)
is foaf:primaryTopic of	wikipedia-en:Brent_Saunders